600 related articles for article (PubMed ID: 29503651)
1. Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice.
Funda DP; Goliáš J; Hudcovic T; Kozáková H; Špíšek R; Palová-Jelínková L
Front Immunol; 2018; 9():290. PubMed ID: 29503651
[TBL] [Abstract][Full Text] [Related]
2. Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells.
Dáňová K; Grohová A; Strnadová P; Funda DP; Šumník Z; Lebl J; Cinek O; Průhová Š; Koloušková S; Obermannová B; Petruželková L; Šedivá A; Fundová P; Buschard K; Špíšek R; Palová-Jelínková L
J Immunol; 2017 Jan; 198(2):729-740. PubMed ID: 27927966
[TBL] [Abstract][Full Text] [Related]
3. Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?
Funda DP; Palová-Jelínková L; Goliáš J; Kroulíková Z; Fajstová A; Hudcovic T; Špíšek R
Front Immunol; 2019; 10():967. PubMed ID: 31139178
[TBL] [Abstract][Full Text] [Related]
4. Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase.
Jun HS; Chung YH; Han J; Kim A; Yoo SS; Sherwin RS; Yoon JW
Diabetologia; 2002 May; 45(5):668-76. PubMed ID: 12107747
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.
Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A
J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799
[TBL] [Abstract][Full Text] [Related]
6. Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease.
Geng L; Solimena M; Flavell RA; Sherwin RS; Hayday AC
Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10055-60. PubMed ID: 9707599
[TBL] [Abstract][Full Text] [Related]
7. GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice.
Zekzer D; Wong FS; Ayalon O; Millet I; Altieri M; Shintani S; Solimena M; Sherwin RS
J Clin Invest; 1998 Jan; 101(1):68-73. PubMed ID: 9421467
[TBL] [Abstract][Full Text] [Related]
8. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.
Chen C; Lee WH; Yun P; Snow P; Liu CP
J Immunol; 2003 Jul; 171(2):733-44. PubMed ID: 12847240
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells.
Machen J; Harnaha J; Lakomy R; Styche A; Trucco M; Giannoukakis N
J Immunol; 2004 Oct; 173(7):4331-41. PubMed ID: 15383562
[TBL] [Abstract][Full Text] [Related]
10. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.
Mukherjee R; Chaturvedi P; Qin HY; Singh B
J Autoimmun; 2003 Nov; 21(3):221-37. PubMed ID: 14599847
[TBL] [Abstract][Full Text] [Related]
11. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with a co-expression DNA plasmid containing GAD65 fragment gene and IL-10 gene induces regulatory CD4(+) T cells that prevent experimental autoimmune diabetes.
Liu X; Zhang S; Li X; Zheng P; Hu F; Zhou Z
Diabetes Metab Res Rev; 2016 Sep; 32(6):522-33. PubMed ID: 26797873
[TBL] [Abstract][Full Text] [Related]
13. Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism.
Gong Z; Pan L; Le Y; Liu Q; Zhou M; Xing W; Zhuo R; Wang S; Guo J
Vaccine; 2010 May; 28(24):4052-8. PubMed ID: 20406664
[TBL] [Abstract][Full Text] [Related]
14. Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice.
Posgai AL; Wasserfall CH; Kwon KC; Daniell H; Schatz DA; Atkinson MA
Sci Rep; 2017 Feb; 7():42372. PubMed ID: 28205558
[TBL] [Abstract][Full Text] [Related]
15. 1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543).
Overbergh L; Decallonne B; Waer M; Rutgeerts O; Valckx D; Casteels KM; Laureys J; Bouillon R; Mathieu C
Diabetes; 2000 Aug; 49(8):1301-7. PubMed ID: 10923629
[TBL] [Abstract][Full Text] [Related]
16. A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice.
Tisch R; Wang B; Atkinson MA; Serreze DV; Friedline R
J Immunol; 2001 Jun; 166(11):6925-36. PubMed ID: 11359854
[TBL] [Abstract][Full Text] [Related]
17. IL-10-conditioned dendritic cells prevent autoimmune diabetes in NOD and humanized HLA-DQ8/RIP-B7.1 mice.
Tai N; Yasuda H; Xiang Y; Zhang L; Rodriguez-Pinto D; Yokono K; Sherwin R; Wong FS; Nagata M; Wen L
Clin Immunol; 2011 Jun; 139(3):336-49. PubMed ID: 21458378
[TBL] [Abstract][Full Text] [Related]
18. Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes.
Saï P; Rivereau AS; Granier C; Haertlé T; Martignat L
Clin Exp Immunol; 1996 Aug; 105(2):330-7. PubMed ID: 8706342
[TBL] [Abstract][Full Text] [Related]
19. Autoantigen-specific protection of non-obese diabetic mice from cyclophosphamide-accelerated diabetes by vaccination with dendritic cells.
Krueger T; Wohlrab U; Klucken M; Schott M; Seissler J
Diabetologia; 2003 Oct; 46(10):1357-65. PubMed ID: 12928772
[TBL] [Abstract][Full Text] [Related]
20. Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.
Kim SK; Tarbell KV; Sanna M; Vadeboncoeur M; Warganich T; Lee M; Davis M; McDevitt HO
Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14204-9. PubMed ID: 15381770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]